2021-2031年北美微生物CRO服务市场报告:范围、细分、动态和竞争分析
市场调查报告书
商品编码
1871484

2021-2031年北美微生物CRO服务市场报告:范围、细分、动态和竞争分析

North America Microbiology CRO Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: | 出版商: The Insight Partners | 英文 133 Pages | 订单完成后即时交付

价格

预计北美微生物学合约研究组织 (CRO) 服务市场将显着成长,到 2031 年将达到约 49.5288 亿美元,高于 2023 年的 24.8824 亿美元。这一成长代表着 2023 年至 2031 年 9.0% 的年复合成长率(CAGR)。

执行摘要和市场分析

北美微生物CRO服务市场正稳步成长,这得益于生物技术和药物研发的进步,以及外包专业实验室功能的趋势日益增长。微生物CRO提供抗菌药物效力测试、无菌测试、环境监测和微生物组分析等关键服务,这些服务对于药物开发、医疗器材测试和生物製药生产至关重要。该地区拥有完善的监管架构、众多大型製药公司以及对生命科学创新的高度重视,为CRO的发展创造了有利环境。此外,对生物製剂和疫苗的日益关注,以及传染病发病率的上升,进一步增加了对可靠的微生物检测和验证服务的需求。製药公司与CRO之间的合作提高了研发效率,加快了产品上市速度,并确保符合FDA和加拿大卫生部等监管机构制定的严格品质标准,从而巩固了北美在微生物研究外包领域的领先地位。

市场区隔分析

北美微生物CRO服务市场可依应用程式、服务类型、微生物和最终用户进行细分:

  • 应用领域:市场分为临床、医疗器材和其他应用领域,其中临床领域在 2023 年占据最大的市场份额。
  • 服务类型:该市场分为检测开发、客製化病毒原液生产、微生物检测等,其中微生物检测在 2023 年占据最大份额。
  • 微生物:此分类包括细菌、真菌、病毒和寄生虫,其中细菌在 2023 年将成为主要类别。
  • 最终用户:市场分为生物技术和製药公司、医疗器材公司和其他公司,其中生物技术和製药公司在 2023 年占据最大份额。

市场展望

专注于微生物检测的合约研究组织(CRO)越来越多地与各利益相关者建立合作关係,以拓展其服务范围。值得注意的是,在生物製药需求不断增长的推动下,2022年和2023年合作活动激增,主要集中在收购、生产协议和产品开发方面。例如,2023年8月,Frontage Laboratories, Inc.及其子公司Frontage Canada, Inc.收购了提供一系列服务的CRO公司Nucro-Technics Inc.。同样,2022年10月,知名医疗技术CRO公司NAMSA收购了总部位于英国的客製化微生物服务实验室Perfectus Biomed Group,从而扩大了NAMSA在多个地区的业务范围。

国家概况

北美微生物CRO服务市场涵盖美国、加拿大和墨西哥,其中美国在2023年占据最大的市场份额。美国被公认为全球最大的微生物CRO市场,预计在整个预测期内将保持这一地位。美国市场的成长归功于CRO对先进技术的应用、临床试验数量的增加以及製药和生物技术公司对研发投入的增加。市场参与者的策略性倡议也是推动成长的关键因素。例如,2024年2月,ICON plc收购了Clinical Research Management, Inc. (ClinicalRM),后者为美国各政府机构提供全面的研究解决方案,从而增强了它们在传染病和疫苗研发方面的能力。

在预测期内,美国微生物CRO市场预计将会成长,这主要得益于CRO微生物检测服务的拓展。例如,Microbiologics于2021年4月扩展了其病毒学服务,以支援药物和疫苗研究人员,并投资新建了一座生物安全3级(BSL-3)实验室,以增强其对包括COVID-19在内的高传染性病原体的检测能力。

公司简介

微生物CRO服务市场的主要参与者包括Microbiologics、Melbec Microbiology、Emery Pharma、TheraIndx Lifesciences Pvt. Ltd.、AVERIN BIOTECH、Statens Serum Institut、ImQuest BioSciences、PACIFIC BIOLABS、Innovotech Inc.和BluTest Laboratories Ltd.。这些公司正在采用各种策略,例如扩张、产品创新以及併购,以增强其产品和服务并提高市场份额。

目录

第一章:引言

第二章:执行概要

  • 关键见解

第三章:研究方法

  • 二手研究
  • 初步研究
    • 假设的提出:
    • 宏观经济因素分析:
    • 发展基础数字:
    • 数据三角测量:
    • 国家层面资料:

第四章:北美微生物CRO市场-主要市场动态

  • 市场驱动因素
    • 大量临床试验外包做法日益普遍
    • 研发投入激增
  • 市场限制
    • 熟练专业人员短缺
  • 市场机会
    • 微生物检测技术的进步
  • 未来趋势
    • 与服务提供者的伙伴关係和合作日益增多
  • 驾驶员和安全带的影响:

第五章:微生物CRO市场-北美分析

  • 2021-2031年北美微生物CRO市场收入
  • 北美微生物CRO市场预测分析

第六章:北美微生物CRO市场分析-依应用领域划分

  • 临床
  • 医疗器材
  • 其他的

第七章:北美微生物学CRO市场分析-依服务类型划分

  • 检测方法开发
  • 客製化病毒式传播材料製作
  • 微生物检测
  • 其他的

第八章:北美微生物CRO市场分析-依微生物分类

  • 细菌
  • 真菌
  • 病毒
  • 寄生虫

第九章:北美微生物CRO市场分析-依最终用户划分

  • 生物技术和製药公司
  • 医疗器材公司
  • 其他的

第十章:北美微生物CRO市场-国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第十一章:微生物CRO服务市场-产业概况

  • 概述
  • 微生物CRO服务市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章:公司简介

  • Microbiologics
  • Melbec Microbiology
  • Emery Pharma
  • TheraIndx Lifesciences Pvt. Ltd.
  • AVERIN BIOTECH
  • Statens Serum Institut
  • ImQuest BioSciences
  • PACIFIC BIOLABS
  • Innovotech Inc.
  • BluTest Laboratories Ltd

第十三章:附录

Product Code: BMIRE00032141

The North America microbiology Contract Research Organization (CRO) services market is projected to grow significantly, reaching approximately US$ 4,952.88 million by 2031, up from US$ 2,488.24 million in 2023. This growth represents a compound annual growth rate (CAGR) of 9.0% from 2023 to 2031.

Executive Summary and Market Analysis

The microbiology CRO services market in North America is experiencing steady growth, fueled by advancements in biotechnology and pharmaceutical research, as well as an increasing trend towards outsourcing specialized laboratory functions. Microbiology CROs play a vital role by offering essential services such as antimicrobial efficacy testing, sterility testing, environmental monitoring, and microbiome analysis, which are crucial for drug development, medical device testing, and biopharmaceutical production. The region benefits from a robust regulatory framework, the presence of major pharmaceutical companies, and a strong emphasis on innovation in life sciences, creating a conducive environment for CRO growth. Furthermore, the rising focus on biologics and vaccines, along with the increasing incidence of infectious diseases, has amplified the demand for dependable microbiological testing and validation services. Collaborations between pharmaceutical firms and CROs are enhancing research efficiency, speeding up time-to-market, and ensuring compliance with stringent quality standards set by regulatory bodies like the FDA and Health Canada, thereby solidifying North America's leadership in outsourced microbiology research.

Market Segmentation Analysis

The North America microbiology CRO services market can be segmented based on application, service type, microorganisms, and end users:

  • Application: The market is divided into clinical, medical device, and other applications, with the clinical segment holding the largest market share in 2023.
  • Service Type: This market is categorized into assay development, custom viral stock production, microbial testing, and others, where microbial testing accounted for the largest share in 2023.
  • Microorganisms: The segmentation includes bacteria, fungi, viruses, and parasites, with bacteria being the dominant category in 2023.
  • End Users: The market is segmented into biotech and pharmaceutical companies, medical device companies, and others, with biotech and pharmaceutical companies holding the largest share in 2023.

Market Outlook

CROs specializing in microbial testing have increasingly formed partnerships with various stakeholders to broaden their service offerings. Notably, partnership activities surged in 2022 and 2023, focusing on acquisitions, manufacturing agreements, and product development, driven by the rising demand for biopharmaceuticals. For instance, in August 2023, Frontage Laboratories, Inc. and its subsidiary Frontage Canada, Inc. acquired Nucro-Technics Inc., a CRO that provides a range of services. Similarly, in October 2022, NAMSA, a prominent MedTech CRO, acquired Perfectus Biomed Group, a UK-based laboratory specializing in customized microbiological services, thereby expanding NAMSA's reach across multiple regions.

Country Insights

The North America microbiology CRO services market includes the US, Canada, and Mexico, with the US holding the largest market share in 2023. The US is recognized as the largest microbiology CRO market globally and is expected to maintain this position throughout the forecast period. The growth in the US market is attributed to the adoption of advanced technologies by CROs, an increasing number of clinical trials, and heightened investment in research and development by pharmaceutical and biotechnology companies. Strategic initiatives by market players are also pivotal in driving growth. For example, in February 2024, ICON plc acquired Clinical Research Management, Inc. (ClinicalRM), which provides comprehensive research solutions to various US government agencies, enhancing their capabilities in infectious diseases and vaccine development.

During the forecast period, the US microbiology CRO market is anticipated to grow, particularly due to the expansion of microbial testing services by CROs. For instance, Microbiologics expanded its virology services in April 2021 to support drug and vaccine researchers, investing in a new biosafety Level 3 (BSL-3) facility to enhance its capabilities in testing for highly infectious pathogens, including COVID-19.

Company Profiles

Key players in the microbiology CRO services market include Microbiologics, Melbec Microbiology, Emery Pharma, TheraIndx Lifesciences Pvt. Ltd., AVERIN BIOTECH, Statens Serum Institut, ImQuest BioSciences, PACIFIC BIOLABS, Innovotech Inc., and BluTest Laboratories Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. North America Microbiology CRO Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Practice of Outsourcing Clinical Studies with Massive Number of Trials
    • 4.1.2 Surging Research and Development Investments
  • 4.2 Market Restraints
    • 4.2.1 Shortage of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Microbiology Testing Technology
  • 4.4 Future Trends
    • 4.4.1 Rise in Partnerships and Collaborations with Service Providers
  • 4.5 Impact of Drivers and Restraints:

5. Microbiology CRO Market - North America Analysis

  • 5.1 North America Microbiology CRO Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Microbiology CRO Market Forecast Analysis

6. North America Microbiology CRO Market Analysis - by Application

  • 6.1 Clinical
    • 6.1.1 Overview
    • 6.1.2 Clinical: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Medical Device
    • 6.2.1 Overview
    • 6.2.2 Medical Device: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Others
    • 6.3.1 Overview
    • 6.3.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Microbiology CRO Market Analysis - by Service Type

  • 7.1 Assay Development
    • 7.1.1 Overview
    • 7.1.2 Assay Development: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Custom Viral Stock Production
    • 7.2.1 Overview
    • 7.2.2 Custom Viral Stock Production: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Microbial Testing
    • 7.3.1 Overview
    • 7.3.2 Microbial Testing: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Microbiology CRO Market Analysis - by Microorganisms

  • 8.1 Bacteria
    • 8.1.1 Overview
    • 8.1.2 Bacteria: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Fungi
    • 8.2.1 Overview
    • 8.2.2 Fungi: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Viruses
    • 8.3.1 Overview
    • 8.3.2 Viruses: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Parasite
    • 8.4.1 Overview
    • 8.4.2 Parasite: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Microbiology CRO Market Analysis - by End User

  • 9.1 Biotech and Pharmaceutical Companies
    • 9.1.1 Overview
    • 9.1.2 Biotech and Pharmaceutical Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Medical Device Companies
    • 9.2.1 Overview
    • 9.2.2 Medical Device Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Microbiology CRO Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Microbiology CRO Market Share - by Application
        • 10.1.1.2.2 United States: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.2.3 United States: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.2.4 United States: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.2.5 United States: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.2.6 United States: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.2.7 United States: North America Microbiology CRO Market Share - by End User
      • 10.1.1.3 Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Microbiology CRO Market Share - by Application
        • 10.1.1.3.2 Canada: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.3.3 Canada: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.3.4 Canada: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.3.5 Canada: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.3.6 Canada: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.3.7 Canada: North America Microbiology CRO Market Share - by End User
      • 10.1.1.4 Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Microbiology CRO Market Share - by Application
        • 10.1.1.4.2 Mexico: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.4.3 Mexico: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.4.4 Mexico: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.4.5 Mexico: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.4.6 Mexico: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.4.7 Mexico: North America Microbiology CRO Market Share - by End User

11. Microbiology CRO Services Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Microbiology CRO Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Microbiologics
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Melbec Microbiology
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Emery Pharma
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 TheraIndx Lifesciences Pvt. Ltd.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 AVERIN BIOTECH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Statens Serum Institut
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ImQuest BioSciences
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 PACIFIC BIOLABS
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Innovotech Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 BluTest Laboratories Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Microbiology CRO Market Segmentation
  • Table 2. Research and Development Investments by Major Pharmaceutical Companies
  • Table 3. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 4. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 6. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Microorganisms
  • Table 7. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 8. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 10. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 11. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 12. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 13. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 14. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 15. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 17. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 18. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 19. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 21. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 22. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 23. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 25. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 26. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 27. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 28. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 29. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 30. Recent Organic Growth Strategies in Microbiology CRO Services Market
  • Table 31. Recent Inorganic Growth Strategies in the Microbiology CRO Services Market
  • Table 32. Glossary of Terms, Microbiology CRO Services Market

List Of Figures

  • Figure 1. North America Microbiology CRO Market Segmentation - Country
  • Figure 2. North America Microbiology CRO Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Microbiology CRO Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Microbiology CRO Market Share (%) - by Application (2023 and 2031)
  • Figure 6. Clinical: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Medical Device: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. North America Microbiology CRO Market Share (%) - by Service Type (2023 and 2031)
  • Figure 10. Assay Development: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Custom Viral Stock Production: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Microbial Testing: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. North America Microbiology CRO Market Share (%) - by Microorganisms (2023 and 2031)
  • Figure 15. Bacteria: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Fungi: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Viruses: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Parasite: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Microbiology CRO Market Share (%) - by End User (2023 and 2031)
  • Figure 20. Biotech and Pharmaceutical Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Medical Device Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. North America Microbiology CRO Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Growth Strategies in Microbiology CRO Services Market